PATENT CLAIM ANALYSIS

Application Number: 16217507
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "093450"]

Abstract:
A method is provided for evaluating agents for the treatment of different intestinal motility disorders, using distinct methodological parts related to musculature and nerves of the GI tract which communicate with the brain. In particular, the present invention provides a method for the selection of an agent effective for the treatment of an intestinal motility disorder, wherein said method comprises: a) a step of spatiotemporal (ST) mapping carried out on a gastrointestinal segment to analyse the effect of said agent on gastrointestinal motility; and b) a step of ex vivo nerve bundle recording carried out on a gastrointestinal segment to analyse the effect of said agent on mesenteric afferent nerve firing. Bacterial strains selected by the methods of the invention and the use of said bacterial strains in the treatment of intestinal motility disorders are also provided.

Claim (Index 30):
The method of claim  1 , wherein said  Lactobacillus reuteri  bacterial strain decreases the transit time of material through the colon when administered to a subject, thereby treating and/or reducing the risk of developing constipation in said subject.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.88608
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705922', '14425470', '15389577', '15981244', '09374142']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.785916728526837
- 35 USC 102 Novelty (BERT): 0.5761221413619063
- Combined Prediction Score: 0.764937269810344
- Mean Citation Score: 407.036758
- Max Citation Score: 488.74036
- Similarity Product: 401.7836830351972

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test